Hemostasis and Thrombosis Unit, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.
Eur Rev Med Pharmacol Sci. 2021 Sep;25(17):5518-5524. doi: 10.26355/eurrev_202109_26663.
In liver cirrhosis, a complex coagulopathy does exist. The aim was to investigate whether a possible chronic consumption coagulopathy is the underlying phenomenon of the disease.
We measured endogenous thrombin generation with and without thrombomodulin (ETP ratio) along with D-Dimer in a group of consecutive 282 cirrhotic patients. Fibrinogen, Platelet count and the Hemorrhagic score were previously computed in the same patients. The ETP ratio represents the resistance to the anticoagulant activity of TM and should be considered as an index of a procoagulant imbalance.
ETP ratio and D-Dimer showed higher values in the cirrhotic patients when compared to controls thus showing a hypercoagulable state. When the patients were divided based on the Hemorrhagic score >7, we found that Fibrinogen, ETP ratio, D-Dimer and the platelet count were significantly different between the two groups. Again, when we considered ETP ratio >0.88, the median value of the cirrhotic patients, all parameters, were statistically different between the two groups. D-Dimer were higher while fibrinogen and platelet count were statistically lower in cirrhotic patients with higher ETP ratio values. Even when the same patients were divided based on their platelet count (</> 100 x 109/L) the results showed a similar behavior. ROC curves showed significant AUCs when the hemorrhagic score was challenged against Fibrinogen, D-Dimer, Platelet count and ETP ratio.
In liver cirrhosis hypercoagulable state is associated with an increase in D-Dimer levels along with a decrease in fibrinogen and platelet count thus indicating a low-grade intravascular coagulation which predicts a high hemorrhagic risk.
在肝硬化中,确实存在一种复杂的凝血功能障碍。本研究旨在探讨是否存在慢性消耗性凝血病,这是否是该病的潜在现象。
我们测量了 282 例连续肝硬化患者的血栓调节蛋白(TM)存在和不存在情况下的内源性凝血酶生成(ETP 比值)和 D-二聚体。在同一患者中,还计算了纤维蛋白原、血小板计数和出血评分。ETP 比值代表 TM 的抗凝活性的抵抗程度,应被视为促凝失衡的指标。
与对照组相比,肝硬化患者的 ETP 比值和 D-二聚体值更高,表明存在高凝状态。当根据出血评分(>7)将患者分组时,我们发现纤维蛋白原、ETP 比值、D-二聚体和血小板计数在两组之间存在显著差异。同样,当我们考虑 ETP 比值>0.88,即肝硬化患者的中位数时,两组之间的所有参数均存在统计学差异。D-二聚体在 ETP 比值较高的肝硬化患者中较高,而纤维蛋白原和血小板计数则统计学上较低。即使根据血小板计数(</>100×109/L)将相同的患者分组,结果也表现出类似的行为。ROC 曲线显示,出血评分与纤维蛋白原、D-二聚体、血小板计数和 ETP 比值相比,具有显著的 AUC。
在肝硬化中,高凝状态与 D-二聚体水平升高以及纤维蛋白原和血小板计数降低相关,这表明存在低水平的血管内凝血,预示着高出血风险。